Cited 17 times in
The effectiveness of the oncolytic activity induced by Ad5/F35 adenoviral vector is dependent on the cumulative cellular conditions of survival and autophagy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김주항 | - |
dc.contributor.author | 송재진 | - |
dc.date.accessioned | 2014-12-18T08:30:00Z | - |
dc.date.available | 2014-12-18T08:30:00Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 1019-6439 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/86423 | - |
dc.description.abstract | To overcome the poor tumor transduction efficiency of adenovirus serotype 5 (Ad5) observed in several types of cancer, the fiber region of Ad5, apart from its tail, was replaced by adenovirus serotype 35 (Ad35). The chimeric Ad5̸F35 adenoviral vector did not exhibit any significant enhancement of transduction efficiency. CD46, a receptor for Ad35, was expressed in relatively small amounts in most of the cancer cells examined. Therefore, we investigated the pivotal factor(s) that render cancer cells susceptible to transduction. We discovered that the tumor transduction efficiency of Ad5/F35 was enhanced in the presence of rapamycin, an autophagy inducer, in some cancer cells. Analysis of survival potential and cell proliferation rates revealed that Ad5/F35 exerted a more pronounced oncolytic effect in cancer cells with higher survival potential in the presence of rapamycin. | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adenoviridae/genetics* | - |
dc.subject.MESH | Antibiotics, Antineoplastic/pharmacology | - |
dc.subject.MESH | Autophagy* | - |
dc.subject.MESH | Cell Line, Tumor | - |
dc.subject.MESH | Cell Survival* | - |
dc.subject.MESH | Cytomegalovirus/genetics | - |
dc.subject.MESH | Genetic Vectors | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Membrane Cofactor Protein/biosynthesis | - |
dc.subject.MESH | Membrane Cofactor Protein/genetics | - |
dc.subject.MESH | Oncolytic Virotherapy | - |
dc.subject.MESH | Oncolytic Viruses/genetics* | - |
dc.subject.MESH | Promoter Regions, Genetic | - |
dc.subject.MESH | Proto-Oncogene Proteins c-akt/metabolism | - |
dc.subject.MESH | Proto-Oncogene Proteins c-bcl-2/metabolism | - |
dc.subject.MESH | Recoverin/biosynthesis | - |
dc.subject.MESH | Recoverin/genetics | - |
dc.subject.MESH | Sirolimus/pharmacology | - |
dc.subject.MESH | TOR Serine-Threonine Kinases/metabolism | - |
dc.subject.MESH | Transduction, Genetic | - |
dc.subject.MESH | bcl-X Protein/metabolism | - |
dc.title | The effectiveness of the oncolytic activity induced by Ad5/F35 adenoviral vector is dependent on the cumulative cellular conditions of survival and autophagy | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | So Y. Kim | - |
dc.contributor.googleauthor | Sujin Kang | - |
dc.contributor.googleauthor | Jae J. Song | - |
dc.contributor.googleauthor | Joo-Hang Kim | - |
dc.identifier.doi | 10.3892/ijo.2013.1812 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00945 | - |
dc.contributor.localId | A02056 | - |
dc.relation.journalcode | J01141 | - |
dc.identifier.eissn | 1791-2423 | - |
dc.identifier.pmid | 23403990 | - |
dc.identifier.url | http://www.spandidos-publications.com/ijo/42/4/1337 | - |
dc.subject.keyword | Adenoviridae/genetics* | - |
dc.subject.keyword | Antibiotics, Antineoplastic/pharmacology | - |
dc.subject.keyword | Autophagy* | - |
dc.subject.keyword | Cell Line, Tumor | - |
dc.subject.keyword | Cell Survival* | - |
dc.subject.keyword | Cytomegalovirus/genetics | - |
dc.subject.keyword | Genetic Vectors | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Membrane Cofactor Protein/biosynthesis | - |
dc.subject.keyword | Membrane Cofactor Protein/genetics | - |
dc.subject.keyword | Oncolytic Virotherapy | - |
dc.subject.keyword | Oncolytic Viruses/genetics* | - |
dc.subject.keyword | Promoter Regions, Genetic | - |
dc.subject.keyword | Proto-Oncogene Proteins c-akt/metabolism | - |
dc.subject.keyword | Proto-Oncogene Proteins c-bcl-2/metabolism | - |
dc.subject.keyword | Recoverin/biosynthesis | - |
dc.subject.keyword | Recoverin/genetics | - |
dc.subject.keyword | Sirolimus/pharmacology | - |
dc.subject.keyword | TOR Serine-Threonine Kinases/metabolism | - |
dc.subject.keyword | Transduction, Genetic | - |
dc.subject.keyword | bcl-X Protein/metabolism | - |
dc.contributor.alternativeName | Kim, Joo Hang | - |
dc.contributor.alternativeName | Song, Jae Jin | - |
dc.contributor.affiliatedAuthor | Kim, Joo Hang | - |
dc.contributor.affiliatedAuthor | Song, Jae Jin | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 42 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1337 | - |
dc.citation.endPage | 1348 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF ONCOLOGY, Vol.42(4) : 1337-1348, 2013 | - |
dc.identifier.rimsid | 28973 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.